logo
09:44 Dec 08

Anthem Biosciences Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
649.85
-4.60 (-0.70%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Anthem Biosciences Ltd. Financials

Anthem Biosciences Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
649.85
-4.60 (-0.70%)
09:44 Dec 08
Quality
image/svg+xml

66/100
High Financial Strength

Valuation
image/svg+xml

23/100
Expensive Valuation

Technical

24/100
Technically Bearish

Strength

8

Weakness

5

Opportunity

0

Threats

0

18.72 %

ROE %

16.07 %

ROA %

9.19

EPS

43.10

BVPS

24.46 %

Net Profit Margin

Mar 2023 Mar 2024 Mar 2025 TTM 2025
Net Sales
1056.92 1419.37 1844.55 2071.25
Operating Expenses +
628.04 914.39 1173.72 1307.14
Raw Material
348.29 640.79 830.62 802.15
Increase Decrease in Cost
-9.01 -41.24 -86.7 61.63
Other Manufacturing Expense
0 0 0 0
Employee Cost
153.24 182.93 260.49 256.4
Miscellaneous Expenses
135.52 131.91 169.31 186.96
Operating Profit
428.88 504.98 670.83 764.11
Other Income
77.07 63.7 85.73 109.47
Depreciation
63.7 81.82 89.37 110.65
Interest
6.76 9.54 10.33 7.71
Profit before tax and exceptio..
435.5 477.32 656.87 755.22
Exceptional Items
61.8 0 0 0
PBT
497.3 477.32 656.87 755.22
Provision for Taxation
112.11 110.01 205.61 239.04
Net Profit
385.18 367.31 451.26 516.17
NET Profit after MI
385.18 367.31 451.26 516.17
EPS
6.75 6.48 8.04 9.22
Operating Profit Margin (%)
40.58 35.58 36.37 36.89
Net Profit Margin (%)
36.44 25.88 24.46 24.92

Anthem Biosciences Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Sep 2025
Promoter 74.70
FII 1.70
Public 7.20
Others 16.40
Shareholder Shares Holding %
Research 360 logo
Download Our App On: